These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30858799)

  • 1. A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity.
    Muddapu VR; Mandali A; Chakravarthy VS; Ramaswamy S
    Front Neural Circuits; 2019; 13():11. PubMed ID: 30858799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-Scale Computational Model of Excitotoxic Loss of Dopaminergic Cells in Parkinson's Disease.
    Muddapu VR; Chakravarthy VS
    Front Neuroinform; 2020; 14():34. PubMed ID: 33101001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.
    Rodriguez MC; Obeso JA; Olanow CW
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S175-88. PubMed ID: 9749591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson's disease.
    Sahai S; Effendi ET; Mahoney EC; Tucker HR; Moolick BJ; Mamone G; Mikkilineni S; Gupta M; Nicholson A; Chua FY; Akhtar K; Hirschstein Z; Molho ES; Pilitsis JG; Shin DS
    Neurosci Lett; 2020 Nov; 739():135443. PubMed ID: 33141067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson's disease.
    Wu ST; Ma Y; Zhang K; Zhang JG
    Chin Med J (Engl); 2012 Nov; 125(22):4072-5. PubMed ID: 23158145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine Selectively Reorganizes Excitatory Inputs to Substantia Nigra Pars Compacta Dopamine Neurons.
    Beaudoin GMJ; Gomez JA; Perkins J; Bland JL; Petko AK; Paladini CA
    J Neurosci; 2018 Jan; 38(5):1151-1159. PubMed ID: 29263240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic neurons interact with nigral dopaminergic neurons to regulate movement in mice.
    Fan JP; Zhang X; Han Y; Ji Y; Gu WX; Wu HC; Zhou C; Xiao C
    Acta Physiol (Oxf); 2023 Mar; 237(3):e13917. PubMed ID: 36598331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease.
    Muddapu VR; Vijayakumar K; Ramakrishnan K; Chakravarthy VS
    Front Neurosci; 2022; 16():797127. PubMed ID: 35516806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep.
    Qiu MH; Yao QL; Vetrivelan R; Chen MC; Lu J
    Cereb Cortex; 2016 Apr; 26(4):1430-9. PubMed ID: 25316334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro.
    Ledonne A; Mango D; Bernardi G; Berretta N; Mercuri NB
    Exp Neurol; 2012 Jan; 233(1):292-302. PubMed ID: 22056941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.
    Aono H; Choudhury ME; Higaki H; Miyanishi K; Kigami Y; Fujita K; Akiyama JI; Takahashi H; Yano H; Kubo M; Nishikawa N; Nomoto M; Tanaka J
    Glia; 2017 Nov; 65(11):1833-1847. PubMed ID: 28836295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitatory drive from the Subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids.
    Freestone PS; Wu XH; de Guzman G; Lipski J
    Eur J Pharmacol; 2015 Nov; 767():144-51. PubMed ID: 26472124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons.
    Ballaz S; Morales I; Rodríguez M; Obeso JA
    J Neurosci Res; 2013 Dec; 91(12):1609-17. PubMed ID: 23996657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
    Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
    Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
    Breit S; Lessmann L; Benazzouz A; Schulz JB
    Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
    Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
    Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels.
    Evans RC; Zhu M; Khaliq ZM
    J Neurosci; 2017 Mar; 37(13):3704-3720. PubMed ID: 28264982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
    Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
    Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.